DTC
SYRS

Deep Track Capital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Deep Track Capital’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-828,485
Closed -$1.78M – 86
2024
Q3 		$1.78M Hold
828,485
– – 0.06% 69
2024
Q2 		$4.27M Hold
828,485
– – 0.13% 59
2024
Q1 		$4.43M Hold
828,485
– – 0.13% 62
2023
Q4 		$6.45M Hold
828,485
– – 0.22% 55
2023
Q3 		$3.27M Buy
+828,485
New +$3.1M 0.13% 58

Other funds holding SYRS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Deep Track Capital's SYRS Position: Q4 2024 in Review

Deep Track Capital sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q4 2024, closing a stake of 828,485 shares — an estimated $1.78M sold.

Deep Track Capital first reported a position in SYRS in Q3 2023 and held it in 5 quarters. The position peaked at $6.45M in Q4 2023. 44 funds tracked by Wall St. Rank hold SYRS as of Q4 2024.

  • Deep Track Capital reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Deep Track Capital sold 828,485 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.78M.
  • Deep Track Capital first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
  • Deep Track Capital's Syros Pharmaceuticals, Inc. Common Stock position peaked at $6.45M in Q4 2023.
  • 44 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Deep Track Capital's 13F filing for Q4 2024, filed 14 Feb 2025.